There is no financial incentive to fund large-scale follow-up studies questioning blockbuster drugs like statins or suggesting off-patent solutions, because no one stands to profit from digging deeper into side effects when the existing narrative works well for the market.
causalpending
Evidence Quote
“The answer, unfortunately, is quite simple. There's no financial incentive. Who is going to fund that follow-up study that questions the blockbuster drug or suggests off-patent solutions? Who stands to profit from digging deeper into side effects when the existing narrative works so well for the market?”
Created: 8/12/2026, 2:28:10 AM
Your notes
Loading notes...